Join

Compare · APEN vs EW

APEN vs EW

Side-by-side comparison of Apollo Endosurgery Inc. (APEN) and Edwards Lifesciences Corporation (EW): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both APEN and EW operate in Industrial Specialties (Health Care), so they compete in similar markets.
  • EW is the larger of the two at $49.50B, about 246.2x APEN ($201.0M).
  • EW has hit the wire 7 times in the past 4 weeks while APEN has been quiet.
  • EW has more recent analyst coverage (25 ratings vs 6 for APEN).
MetricAPENEW
Company
Apollo Endosurgery Inc.
Edwards Lifesciences Corporation
Price
$9.99+0.71%
$85.52-0.51%
Market cap
$201.0M
$49.50B
1M return
-
+3.36%
1Y return
-
+12.07%
Industry
Industrial Specialties
Industrial Specialties
Exchange
NASDAQ
NYSE
IPO
News (4w)
0
7
Recent ratings
6
25
APEN

Apollo Endosurgery Inc.

Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to place full thickness sutures and secure the approximation of tissue through a flexible endoscope. It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, and delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands; and Orbera Coach, a digital and remotely delivered aftercare program. The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Brazil, Australia, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.

EW

Edwards Lifesciences Corporation

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases. The company also provides surgical heart valve therapy products, such as pericardial valves for aortic and mitral surgical valve replacement; aortic heart valves; annuloplasty rings; cardiac cannula devices; beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation, as well as various procedure-enabling platforms to advance minimally invasive surgery. In addition, it offers critical care products, such as hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings; pulmonary artery catheters; arterial pressure monitoring products, oximetry central venous catheters, as well as monitoring platforms that display a patient's physiological information; and Acumen Hypotension Prediction Index, which alerts clinicians in advance of a patient developing low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Latest APEN

Latest EW